Pyrosequencing Analysis of Thrombosis-Associated Risk Markers
Open Access
- 1 August 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 51 (8) , 1549-1552
- https://doi.org/10.1373/clinchem.2005.049932
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Association of pharmacokinetic (CYP2C9) and pharmacodynamic (factors II, VII, IX, and X; proteins S and C; and γ-glutamyl carboxylase) gene variants with warfarin sensitivityBlood, 2004
- Genetic Evidence That Nitric Oxide Modulates HomocysteineArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene clusterBritish Journal of Haematology, 2003
- Combined carrier status of prothrombin 20210A and factor XIII-A Leu34 alleles as a strong risk factor for myocardial infarction: evidence of a gene-gene interactionBlood, 2003
- Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosisClinica Chimica Acta; International Journal of Clinical Chemistry, 2003
- Is the factor XIII 34Val/Leu polymorphism a protective factor for cerebrovascular disease?British Journal of Haematology, 2003
- Modulation of thrombophilia genes by environmental factors.Pathophysiology of Haemostasis and Thrombosis, 2002
- Platelet Glycoprotein IIIa Pl A Polymorphism, Fibrinogen, and Platelet AggregabilityCirculation, 2001
- Factor V Leiden: the venous thrombotic risk in thrombophilic familiesBritish Journal of Haematology, 2000
- Role of hemostatic gene polymorphisms in venous and arterial thrombotic diseaseBlood, 2000